Skip to main content

Animations

MJFF Publications

7411 - 7420 of 8715 Results
Title
Year
  • Year
  • 2025
  • 2022
  • 2020
  • 2016
  • 2022
  • 2021
  • 2022
  • 2018
  • 2022
  • 2013
  • Summary Details
    OPEN
    Title: Longitudinal neuromelanin changes in prodromal and early Parkinson’s disease in humans and rat model
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcaf204
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Parkinson’s Progression Markers Initiative (PPMI) Online expands biomarker research in Parkinson’s disease (PD) (P9-11.006)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.98.18_supplement.1529
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Cortical volume abnormalities in posttraumatic stress disorder: an ENIGMA-psychiatric genomics consortium PTSD workgroup mega-analysis
    Journal Name: Molecular Psychiatry
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41380-020-00967-1
    Citation Count: 85
  • Summary Details
    OPEN
    Title: α‐synuclein genetic variability: A biomarker for dementia in Parkinson disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.24664
    Citation Count: 93
  • Summary Details
    OPEN
    Title: Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-022-01388-7
    Citation Count: 77
  • Summary Details
    OPEN
    Title: miRMaster 2.0: multi-species non-coding RNA sequencing analyses at scale
    Journal Name: Nucleic Acids Research
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/nar/gkab268
    Citation Count: 40
  • Summary Details
    OPEN
    Title: Diagnostic classification of Parkinson’s disease based on non-motor manifestations and machine learning strategies
    Journal Name: Neural Computing and Applications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00521-022-07256-8
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Monitoring PARKIN RBR Ubiquitin Ligase Activation States with UbFluor
    Journal Name: Current Protocols in Chemical Biology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/cpch.45
    Citation Count: 6
  • Summary Details
    RESTRICTED
    Title: CRISPR/Cas9‐Based Functional Genomics in Human Induced Pluripotent Stem Cell–Derived Models: Can “the Stars Align” for Neurodegenerative Diseases?
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28998
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Endogenous LRRK2 dimerizes and translocates to novel membrane compartments during monocyte activation
    Journal Name: The FASEB Journal
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1096/fasebj.27.1_supplement.873.17
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.